Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study
A chimeric antigen receptor-modified T-cell therapy recipient developed severe coronavirus disease 2019, intractable RNAemia, and viral replication lasting >2 months.
COVID-19 Rapid Treatment Guidelines for Clinicians
Explore frequently updated evidence-based guidelines to support patients, clinicians and other health-care professionals in their decisions about treatment and management of patients with COVID-19 infection.
Click here for the latest guidance.
Additional OUP Resources
Additional IDSA Resources
Society Members
For your free access to this journal, log in via the IDSA members area.
Register to receive email alerts, and keep up to date with the latest Clinical Infectious Diseases articles as soon as they are published online. And, with the IDSA Journals app, it's easy to stay connected, giving you the freedom to read the journal both online and offline, on your iPad, iPhone, or iPod Touch.
Sign up for alerts
Trending Articles
Discover the top Clinical Infectious Diseases articles, sorted by Altmetric Score, that have been mentioned online in the past month.

In the many tributes that have poured in since the passing of John Bartlett on January 19, 2021, the phrase that reverberates is “the passing of a legend.” I had known John for 50 years since we met in 1970 and worked closely with him for 8 years, initially at Sepulveda VA Hospital in California and then at Tufts Medical ...
Molecular assays have revolutionized the diagnosis of acute respiratory tract infections. However, many unanswered questions about the optimal use and cost-effectiveness of these tests remain. Additional prospective diagnostic studies are needed to measure impact on medical decision making and clinical outcomes.
Daptomycin is one of the few treatment options for infections caused by enterococci that are resistant to ampicillin and vancomycin, such as vancomycin-resistant Enterococcus faecium . The emergence and clinical significance of daptomycin-resistant enterococci and evolving microbiologic, pharmacokinetic-pharmacodynamic, ...


